187 related articles for article (PubMed ID: 1711943)
1. Serum amyloid A concentrations in giant-cell arteritis and polymyalgia rheumatica: a useful test in the management of the disease.
Hachulla E; Saile R; Parra HJ; Hatron PY; Gosset D; Fruchart JC; Devulder B
Clin Exp Rheumatol; 1991; 9(2):157-63. PubMed ID: 1711943
[TBL] [Abstract][Full Text] [Related]
2. Soluble interleukin 2 receptors in polymyalgia rheumatica/giant cell arteritis. Clinical and laboratory correlations.
Salvarani C; Macchioni P; Boiardi L; Rossi F; Casadei Maldini M; Mancini R; Beltrandi E; Spacca C; Lodi L; Portioli I
J Rheumatol; 1992 Jul; 19(7):1100-6. PubMed ID: 1512765
[TBL] [Abstract][Full Text] [Related]
3. Erythrocyte sedimentation rate and C reactive protein in the assessment of polymyalgia rheumatica/giant cell arteritis on presentation and during follow up.
Kyle V; Cawston TE; Hazleman BL
Ann Rheum Dis; 1989 Aug; 48(8):667-71. PubMed ID: 2782977
[TBL] [Abstract][Full Text] [Related]
4. Plasma adrenomedullin levels in patients with polymyalgia rheumatica and giant cell arteritis.
Garcia-Unzueta MT; Martínez-Taboada VM; Amado-Señarís JA; Rodríguez-Valverde V
Clin Exp Rheumatol; 2006; 24(2 Suppl 41):S6-9. PubMed ID: 16859588
[TBL] [Abstract][Full Text] [Related]
5. Serum markers associated with disease activity in giant cell arteritis and polymyalgia rheumatica.
van der Geest KS; Abdulahad WH; Rutgers A; Horst G; Bijzet J; Arends S; Roffel MP; Boots AM; Brouwer E
Rheumatology (Oxford); 2015 Aug; 54(8):1397-402. PubMed ID: 25724206
[TBL] [Abstract][Full Text] [Related]
6. Circulating CD8+ T cells in polymyalgia rheumatica and giant cell arteritis: a review.
Martinez-Taboada VM; Blanco R; Fito C; Pacheco MJ; Delgado-Rodriguez M; Rodriguez-Valverde V
Semin Arthritis Rheum; 2001 Feb; 30(4):257-71. PubMed ID: 11182026
[TBL] [Abstract][Full Text] [Related]
7. Laboratory investigations useful in the evaluation of polymyalgia rheumatica (PMR) and giant cell arteritis (GCA).
Hazleman B
Clin Exp Rheumatol; 2000; 18(4 Suppl 20):S29-31. PubMed ID: 10948756
[TBL] [Abstract][Full Text] [Related]
8. Relationship of the erythrocyte sedimentation rate to acute phase proteins in polymyalgia rheumatica and giant cell arteritis.
Park JR; Jones JG; Hazleman BL
Ann Rheum Dis; 1981 Oct; 40(5):493-5. PubMed ID: 6171213
[TBL] [Abstract][Full Text] [Related]
9. Alpha 1-antichymotrypsin, C-reactive protein and erythrocyte sedimentation rate in polymyalgia rheumatica and giant cell arteritis.
Pountain GD; Calvin J; Hazleman BL
Br J Rheumatol; 1994 Jun; 33(6):550-4. PubMed ID: 8205403
[TBL] [Abstract][Full Text] [Related]
10. Microheterogeneity of alpha 1-antichymotrypsin in the management of giant-cell arteritis and polymyalgia rheumatica.
Hachulla E; Laine A; Hayem A
Clin Sci (Lond); 1990 Jun; 78(6):557-64. PubMed ID: 2165887
[TBL] [Abstract][Full Text] [Related]
11. Serum immunoglobulin G4 in giant cell arteritis and polymyalgia rheumatica.
Burkel M; Arndt F; Schirmer JH; Moosig F; Holle JU
Clin Exp Rheumatol; 2017; 35 Suppl 103(1):94-97. PubMed ID: 27974093
[TBL] [Abstract][Full Text] [Related]
12. Homocysteine levels in polymyalgia rheumatica and giant cell arteritis: influence of corticosteroid therapy.
Martinez-Taboada VM; Bartolome MJ; Fernandez-Gonzalez MD; Blanco R; Rodriguez-Valverde V; Lopez-Hoyos M
Rheumatology (Oxford); 2003 Sep; 42(9):1055-61. PubMed ID: 12730520
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic difficulties in polymyalgia rheumatica cases with normal erythrocyte sedimentation rate and C-reactive protein values.
Kara M; Alp G; Koç AM
Medicine (Baltimore); 2023 Sep; 102(39):e35385. PubMed ID: 37773830
[TBL] [Abstract][Full Text] [Related]
14. Giant cell arteritis and polymyalgia rheumatica in northwestern Turkey: Clinical features and epidemiological data.
Pamuk ON; Dönmez S; Karahan B; Pamuk GE; Cakir N
Clin Exp Rheumatol; 2009; 27(5):830-3. PubMed ID: 19917168
[TBL] [Abstract][Full Text] [Related]
15. CD8+ lymphocyte subset in polymyalgia rheumatica and arteritis temporalis. Inverse relationship between the acute hepatic phase reactants and the CD8+ T-cell subset.
Elling H; Elling P; Olsson A
Clin Exp Rheumatol; 1989; 7(6):627-30. PubMed ID: 2533002
[TBL] [Abstract][Full Text] [Related]
16. Low serum levels of DHEAS in untreated polymyalgia rheumatica/giant cell arteritis.
Narváez J; Bernad B; Díaz Torné C; Momplet JV; Montpel JZ; Nolla JM; Valverde-García J
J Rheumatol; 2006 Jul; 33(7):1293-8. PubMed ID: 16783861
[TBL] [Abstract][Full Text] [Related]
17. Leukocyte Dynamics Reveal a Persistent Myeloid Dominance in Giant Cell Arteritis and Polymyalgia Rheumatica.
van Sleen Y; Graver JC; Abdulahad WH; van der Geest KSM; Boots AMH; Sandovici M; Brouwer E
Front Immunol; 2019; 10():1981. PubMed ID: 31507597
[TBL] [Abstract][Full Text] [Related]
18. Utility of erythrocyte sedimentation rate and C-reactive protein for the diagnosis of giant cell arteritis.
Kermani TA; Schmidt J; Crowson CS; Ytterberg SR; Hunder GG; Matteson EL; Warrington KJ
Semin Arthritis Rheum; 2012 Jun; 41(6):866-71. PubMed ID: 22119103
[TBL] [Abstract][Full Text] [Related]
19. Elevation of von Willebrand factor is independent of erythrocyte sedimentation rate and persists after glucocorticoid treatment in giant cell arteritis.
Federici AB; Fox RI; Espinoza LR; Zimmerman TS
Arthritis Rheum; 1984 Sep; 27(9):1046-9. PubMed ID: 6332630
[TBL] [Abstract][Full Text] [Related]
20. Procalcitonin at the onset of giant cell arteritis and polymyalgia rheumatica: the GRACG prospective study.
Schmidt J; Duhaut P; Bourgeois AM; Salle V; Smail A; Chatelain D; Betsou F; Mazière JC; Ducroix JP;
Rheumatology (Oxford); 2009 Feb; 48(2):158-9. PubMed ID: 19098302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
